Clinical trial
Microbiome, Inflammation and Genetics as a Target for Precision Medicine in AThERosclerosis
NCT03434483 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiome, Inflammation and Genetics as a Target for Precision Medicine in AThERosclerosis
- Lead sponsor
- Hospital General Universitario Gregorio Marañon
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 25, 2018
- Completion date
- February 8, 2021
- Enrollment
- 156 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.